Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
Human Gene Therapy. Clinical Development
|
March 23, 2016
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Guo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Human Gene Therapy. Clinical Development
|
March 23, 2016
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Guo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Toxicologic Pathology
|
April 25, 2024
Considerations for the Identification and Conveyance of Clinical Pathology Findings in Preclinical Toxicity Studies: Results From the 9th ESTP International Expert Workshop
Tara Arndt, Monika Keresztes, Blanck Olivier, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
Human Gene Therapy. Clinical Development
|
March 23, 2016
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Guo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Human Gene Therapy. Clinical Development
|
March 23, 2016
Safety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia
Guo-jie Ye, Ewa Budzynski, Peter Sonnentag, et al.
Toxicologic Pathology
|
April 25, 2024
Considerations for the Identification and Conveyance of Clinical Pathology Findings in Preclinical Toxicity Studies: Results From the 9th ESTP International Expert Workshop
Tara Arndt, Monika Keresztes, Blanck Olivier, et al.
Page
of 2